Is Sophiris Bio (SPHS) finally turning around?
Following a year long downtrend after management followed through with a secondary offering, my chart shows a possible cement floor at 1.80. Higher accumulation and a recent uptrend could mean a lot of upside for the drug development company.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。